Comparison of 1 mg and 2 mg Overnight Dexamethasone Suppression Tests for the Screening of Cushing's Syndrome in Obese Patients

Creative Commons License

ŞAHİN M., Kebapcilar L., Taslipinar A., Azal O., Ozgurtas T., Corakci A., ...Daha Fazla

INTERNAL MEDICINE, cilt.48, sa.1, ss.33-39, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 1
  • Basım Tarihi: 2009
  • Doi Numarası: 10.2169/internalmedicine.48.1234
  • Dergi Adı: INTERNAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.33-39
  • Anahtar Kelimeler: Cushing's syndrome (CS), obesity, insulin resistance, 1 mg / 2 mg overnight dexamethasone suppression test, DIFFERENTIAL-DIAGNOSIS, DIABETIC-PATIENTS, CIRCADIAN-RHYTHM, CORTISOL, PLASMA
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Hayır

Özet

Objective Obesity is currently a major public health problem and one of the potential underlying causes of obesity in a minority of patients is Cushing's syndrome (CS). Traditionally, the gold standard screening test for CS is 1 mg dexamethasone overnight suppression test. However, it is known that obese subjects have high false positive results with this test.